当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Biotechnology: CRISPR–Cas becoming more human
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-09-01 , DOI: 10.1038/nrd.2017.167 Kim Baumann
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-09-01 , DOI: 10.1038/nrd.2017.167 Kim Baumann
In the past few years, the CRISPR–Cas technology has been developed to precisely edit genomic DNA; so far, these approaches have been used mainly in cultured cells or in animal embryo models, but only a few studies have reported their use in human embryos. Ma
中文翻译:
生物技术:CRISPR–Cas变得更加人性化
在过去的几年中,已经开发了CRISPR–Cas技术来精确编辑基因组DNA。迄今为止,这些方法主要用于培养细胞或动物胚胎模型中,但只有少数研究报道了它们在人类胚胎中的用途。嘛
更新日期:2017-09-04
中文翻译:
生物技术:CRISPR–Cas变得更加人性化
在过去的几年中,已经开发了CRISPR–Cas技术来精确编辑基因组DNA。迄今为止,这些方法主要用于培养细胞或动物胚胎模型中,但只有少数研究报道了它们在人类胚胎中的用途。嘛